CG Oncology, Inc. (CGON) P/E Ratio

CG Oncology, Inc. PE Ratio

The price-to-earnings (P/E) ratio tells you how many dollars investors pay for each dollar of a company's annual profit. It is market capitalization divided by net income over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher P/E means investors are paying more for each dollar of current earnings, often because they expect profits to grow; a negative P/E means the company lost money over those four quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.

• CG Oncology, Inc. pe ratio for the quarter ending 2026-06-30 was -27.95, a change of -12.48 year-over-year.
• CG Oncology, Inc. pe ratio for the quarter ending 2026-03-31 was -31.93, a change of -14.24 year-over-year.
• CG Oncology, Inc. pe ratio for the quarter ending 2025-12-31 was -20.83, a change of 3.98 year-over-year.
• CG Oncology, Inc. pe ratio for the quarter ending 2025-09-30 was -20.82, a change of 14.19 year-over-year.
• CG Oncology, Inc. pe ratio for fiscal 2026 was -27.95.
• CG Oncology, Inc. pe ratio for fiscal 2025 was -20.83, a change of 3.98 from fiscal 2024.
• CG Oncology, Inc. pe ratio for fiscal 2024 was -24.81.